Chemoinformaics analysis of ETHYL FURAN-2-CARBOXYLATE
| Molecular Weight | 140.138 | nRot | 2 |
| Heavy Atom Molecular Weight | 132.074 | nRig | 0 |
| Exact Molecular Weight | 140.047 | nRing | 1 |
| Solubility: LogS | -4.563 | nHRing | 1 |
| Solubility: LogP | 4.53 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 19.4303 |
| nHD | 0 | BPOL | 12.3657 |
| QED | 0.492 |
| Synth | 1.502 |
| Natural Product Likeliness | 0.699 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.198 |
| MDCK | 0.0000182 |
| BBB | 0.95 |
| PPB | 0.94866 |
| VDSS | 2.134 |
| FU | 0.0529814 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.687 |
| CYP2c19-inh | 0.492 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.569 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.089 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.166 |
| CL | 8.043 |
| T12 | 0.345 |
| hERG | 0.03 |
| Ames | 0.007 |
| ROA | 0.062 |
| SkinSen | 0.426 |
| Carcinogencity | 0.077 |
| EI | 0.988 |
| Respiratory | 0.335 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.912172 |